Development of disease-specific microbiome-targeted therapeutics
Development of anti-inflammatory, anti-cancer immune-enhancing pharmabiotics
Development of microbiome-mediated therapies targeting autoimmunity, transplant rejection, and neurological diseases
Vision
To lead the global market of microbiome-mediated therapeutics
To lead the global development of drugs against incurable diseases
